Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Clinical Trials Arena20:30Pfizer Pharma
pharmaphorum18:41Pfizer Pharma
PMLiVE21:32Pfizer Pharma
Biopharma Reporter23:22Pfizer Biotechnology Pharma
Benzinga04:41Pfizer Pharma
Pharmaceutical Technology01:43The Lancet
Simply Wall St16:26
Zacks23:04Pfizer Pharma
Benzinga01:16
ENDPOINTS00:56Pharma
Yesterday
Simply Wall St16:26 19-Sept-24
TipRanks06:25 19-Sept-24
Pharmaceutical Technology01:43 19-Sept-24
In the last 7 days
GlobeNewswire (Press Release)15:02 18-Sept-24
International Financing Review02:25 14-Sept-24
ENDPOINTS00:56 14-Sept-24
Law36023:56 13-Sept-24
TipRanks22:07 13-Sept-24
GlobeNewswire (Press Release)16:32 13-Sept-24
Valneva (Press Release)06:08 13-Sept-24
In the last month
PMLiVE21:32 6-Sept-24
GlobeNewswire (Press Release)02:11 5-Sept-24
ENDPOINTS05:38 4-Sept-24
Benzinga04:41 4-Sept-24
Benzinga01:16 4-Sept-24
Scrip Pharma Intelligence00:53 4-Sept-24
Biopharma Reporter23:22 3-Sept-24
Zacks23:04 3-Sept-24
TipRanks20:33 3-Sept-24
Clinical Trials Arena20:30 3-Sept-24
FierceBiotech19:04 3-Sept-24
pharmaphorum18:41 3-Sept-24
Valneva (Press Release)14:59 3-Sept-24
DGAP00:10 21-Aug-24
The Scotsman13:54 20-Aug-24
view more headlines
19 Sept 16:26

Valneva News

Latest news on Valneva, a French biotech company that develops and commercialises vaccines for infectious diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.